Citations (15)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Valentin R Wydra, Raphael B Ditzinger, Nico J Seidler, Frederik W Hacker & Stefan A Laufer. (2023) A patent review of MAPK inhibitors (2018 – present). Expert Opinion on Therapeutic Patents 33:6, pages 421-444.
Read now
Read now
Articles from other publishers (14)
Zhijia Li, Bo Yin, Shuangqian Zhang, Zhigang Lan & Lan Zhang. (2023) Targeting protein kinases for the treatment of Alzheimer's disease: Recent progress and future perspectives. European Journal of Medicinal Chemistry 261, pages 115817.
Crossref
Crossref
Joonhong Jun, Hyungwoo Moon, Songyi Yang, Junghun Lee, Jihyun Baek, Hyejin Kim, Hyunwook Cho, Kyungrim Hwang, Soyeon Ahn, Yuro Kim, Gibeom Kim, HyunTae Kim, Hoseok Kwon & Jung-Mi Hah. (2023) Carbamate JNK3 Inhibitors Show Promise as Effective Treatments for Alzheimer’s Disease: In Vivo Studies on Mouse Models. Journal of Medicinal Chemistry 66:9, pages 6372-6390.
Crossref
Crossref
Wenchao Lu, Yao Liu, Yang Gao, Qixiang Geng, Deepak Gurbani, Lianbo Li, Scott B. Ficarro, Cynthia J. Meyer, Dhiraj Sinha, Inchul You, Jason Tse, Zhixiang He, Wenzhi Ji, Jianwei Che, Audrey Y. Kim, Tengteng Yu, Kenneth Wen, Kenneth C. Anderson, Jarrod A. Marto, Kenneth D. Westover, Tinghu Zhang & Nathanael S. Gray. (2023) Development of a Covalent Inhibitor of c-Jun N-Terminal Protein Kinase (JNK) 2/3 with Selectivity over JNK1. Journal of Medicinal Chemistry 66:5, pages 3356-3371.
Crossref
Crossref
Ekta Lathwal & Suresh Kumar. (2023) A Review of the Various Synthetic Approaches to Access Aurone Derivatives and
their Biological Activities. Current Organic Chemistry 27:4, pages 308-351.
Crossref
Crossref
Joonhong Jun, Jihyun Baek, Dahyun Kang, Hyungwoo Moon, Hyejin Kim, Hyunwook Cho & Jung-Mi Hah. (2023) Novel 1,4,5,6-tetrahydrocyclopenta[d]imidazole-5-carboxamide-based JNK3 inhibitors: Design, synthesis, molecular docking, and therapeutic potential in neurodegenerative diseases. European Journal of Medicinal Chemistry 245, pages 114917.
Crossref
Crossref
Joonhong Jun, Songyi Yang, Junghun Lee, Hyungwoo Moon, Jinwoong Kim, Hoyong Jung, Daseul Im, Youri Oh, Miyoung Jang, Hyunwook Cho, Jihyun Baek, Hyejin Kim, Dahyun Kang, Hyunah Bae, Chanwool Tak, Kyungrim Hwang, Hoseok Kwon, HyunTae Kim & Jung-Mi Hah. (2023) Discovery of novel imidazole chemotypes as isoform-selective JNK3 inhibitors for the treatment of Alzheimer's disease. European Journal of Medicinal Chemistry 245, pages 114894.
Crossref
Crossref
Pengxia Qin, Yingying Ran, Yujing Liu, Chao Wei, Xiaoyi Luan, Haoqian Niu, Jie Peng, Jie Sun & Jingde Wu. (2022) Recent advances of small molecule JNK3 inhibitors for Alzheimer’s disease. Bioorganic Chemistry 128, pages 106090.
Crossref
Crossref
Yumeng Zhu, Wen Shuai, Min Zhao, Xiaoli Pan, Junping Pei, Yongya Wu, Faqian Bu, Aoxue Wang, Liang Ouyang & Guan Wang. (2022) Unraveling the Design and Discovery of c-Jun N-Terminal Kinase Inhibitors and Their Therapeutic Potential in Human Diseases. Journal of Medicinal Chemistry 65:5, pages 3758-3775.
Crossref
Crossref
Mohammed I. El-Gamal, Seyed-Omar Zaraei, Moustafa M. Madkour & Hanan S. Anbar. (2022) Evaluation of Substituted Pyrazole-Based Kinase Inhibitors in One Decade (2011–2020): Current Status and Future Prospects. Molecules 27:1, pages 330.
Crossref
Crossref
Yangbo Feng, HaJeung ParkJae Cheon RyuSung OK Yoon. (2021)
N
-Aromatic-Substituted Indazole Derivatives as Brain-Penetrant and Orally Bioavailable JNK3 Inhibitors
. ACS Medicinal Chemistry Letters 12:10, pages 1546-1552.
Crossref
Crossref
Serhii A. Liakhov, Igor A. Schepetkin, Olexander S. Karpenko, Hanna I. Duma, Nadiia M. Haidarzhy, Liliya N. Kirpotina, Anastasia R. Kovrizhina, Andrei I. Khlebnikov, Irina Y. Bagryanskaya & Mark T. Quinn. (2021) Novel c-Jun N-Terminal Kinase (JNK) Inhibitors with an 11H-Indeno[1,2-b]quinoxalin-11-one Scaffold. Molecules 26:18, pages 5688.
Crossref
Crossref
Yuling Tang, Guanghui Yang, Yuxiang Li, Ming Wang, Gebin Li & Yanxin Hu. (2021) Protective effects of SP600125 on mice infected with H1N1 influenza A virus. Archives of Virology 166:8, pages 2151-2158.
Crossref
Crossref
Li Chen, Xuantong Zhou, Xiangyi Kong, Zhaohui Su, Xiangyu Wang, Sen Li, Aiping Luo, Zhihua Liu, Yi Fang & Jing Wang. (2021) The Prognostic Significance of Anisomycin-Activated Phospho-c-Jun NH2-Terminal Kinase (p-JNK) in Predicting Breast Cancer Patients’ Survival Time. Frontiers in Cell and Developmental Biology 9.
Crossref
Crossref
Yangbo Feng, HaJeung Park, Luke Bauer, Jae Cheon Ryu & Sung OK Yoon. (2020) Thiophene-Pyrazolourea Derivatives as Potent, Orally Bioavailable, and Isoform-Selective JNK3 Inhibitors. ACS Medicinal Chemistry Letters 12:1, pages 24-29.
Crossref
Crossref